Treatment of chronic myeloid leukemia when imatinib fails.
about
c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-Activated LeukemiasQuantitative modeling of chronic myeloid leukemia: insights from radiobiologyTargeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias.
P2860
Treatment of chronic myeloid leukemia when imatinib fails.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of chronic myeloid leukemia when imatinib fails.
@en
Treatment of chronic myeloid leukemia when imatinib fails.
@nl
type
label
Treatment of chronic myeloid leukemia when imatinib fails.
@en
Treatment of chronic myeloid leukemia when imatinib fails.
@nl
prefLabel
Treatment of chronic myeloid leukemia when imatinib fails.
@en
Treatment of chronic myeloid leukemia when imatinib fails.
@nl
P2093
P2860
P1476
Treatment of chronic myeloid leukemia when imatinib fails.
@en
P2093
Rüdiger Hehlmann
Susanne Jung-Munkwitz
Susanne Saussele
P2860
P304
P356
10.1517/14656566.2011.533169
P407
P577
2011-02-01T00:00:00Z